Podcasts about pharmacy practice

Listen in as our expert panel discusses medications for management of opioid use disorder. They'll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the University of South Carolina School of Medicine, GreenvilleCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Varisco reports a financial relationship [cardiology, inflammatory bowel disease] with HEALIX Infusion Therapy (research consultant).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Management of Opioid Use DisorderChart: Treatment of Opioid WithdrawalFAQ: Treatment of Acute Pain in Opioid Use DisorderFAQ: Meds for Opioid OverdoseSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don't miss this preview of one of the most anticipated events of the conference! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drs. Adrian Wong, Sandra Kane-Gill, and Alexandre Chan discuss their ACCP Committee work with associate editor, Dr. Alan Zillich. The committees' work resulted in two papers describing the current and future role of AI in clinical pharmacy practice, research, and scholarship. Read the full-text manuscripts: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70004 and https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70003.

In this episode, our guest is Tom Campbell, the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. Dr. Campbell received his Pharm.D. degree from the University of Tennessee College of Pharmacy and received board certification in pharmacotherapy in 1995. His prior work experience includes a pharmacy practice residency with VA Medical Center in Memphis, Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He also served as Clinical Assistant Professor at Auburn University. Dr. Campbell has served as President of the Tennessee Pharmacists Association and served on the Board of Directors. He is a member of AACP, ASHP, APhA, CPFI and TPA. He's a recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award which was established to recognize a school or college of pharmacy dean who has made significant contributions to the APhA-ASP Chapter and promoted with distinction the welfare of student pharmacists through various community service, leadership and professional activities. Dr. Campbell is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN. He has traveled to Central America as part of medical mission campaigns numerous times. Dr. Campbell and his late wife, Susan, have three sons.During the discussion, we explored questions around:How faith influences our daily work in healthcareThe ways faith impacts health behaviors and decision-makingThe role faith plays in job satisfaction and professional fulfillmentIt was inspiring to engage in meaningful dialogue with a leader who also sees their work as a calling to serve others. I'm grateful to Dean Campbell at Lipscomb University for fostering conversations that remind us of the deeper purpose behind our careers. ★ Support this podcast on Patreon ★

During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Don Roosan, PharmD, PhD, joined Over the Counter to discuss ChatGPT in pharmacy practice, how it is being used right now, and the possibilities of AI's future role in health care.

In this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They'll discuss when antibiotics are appropriate, which antibiotics to use, and other management tips.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Managing Community-Acquired Pneumonia and Aspiration Pneumonia in AdultsFAQ: Antibiotic Therapy: When Are Shorter Courses Better?Chart: Managing Cough and Cold SymptomsSend us a textCheck out our NEW podcasts. Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy's recent ML model research, key findings, and the potential applications of these models across different patient populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Pharmacy View Podcast's Full Scope Pharmacy Leadership stream, host, Chantelle Turner, a Pharmacist Leadership and Business Coach at TURN Pharmacy Leadership, speaks with Kristina Fox, a Community Pharmacist and Pharmacy owner of Complete Care Pharmacy, Rosny Park. Kristina shares their transformative journey in reshaping Complete Care Pharmacy in Rosny Park. Kristina's passion for implementing innovative healthcare services led to the creation of a scalable Pharmacy model, one that expanded far beyond their initial intentions. They reflect on the challenges of managing change, addressing staff burnout, and overcoming operational inefficiencies that hindered patient care. The conversation highlights how leadership and innovation in community Pharmacy can drive meaningful change. Kristina describes their approach to innovation as one of problem-solving rather than entrepreneurship. They focus on identifying inefficiencies and seeking practical solutions, which led to a complete overhaul of systems, processes, and Pharmacy layouts. The success of this transformation was due to the collective effort of the team, including Pharmacists, Pharmacy assistants, and front-of-shop staff. Kristina credits their support network, both professionally and personally, as a major factor in the success of the model. A major turning point for Kristina's team was realising that merely adding more staff was not enough to improve operations. Facing operational chaos and the growing complexity of prescriptions, Kristina introduced a "digital basket" system to balance digital, paper, and vaccination requests. This idea prompted a shift from reactive problem-solving to a more visionary approach. Kristina sought the expertise of industry professionals to identify the right technology partners, and while initially facing resistance from developers, achieving even partial success was seen as a significant victory. Kristina advocates for starting rather than waiting for a perfect plan. They believe that large corporations often become paralysed by decision-making, whereas their Pharmacy embraced an iterative approach, launching a version one and refining it based on real-world feedback. Kristina also discusses how this approach applied to the development of the Complete Care Pharmacy model, emphasising the importance of risk-taking, continuous improvement, and teamwork in driving innovation within Pharmacy practice. Effective communication is another key theme Kristina explores in leadership. By engaging all team members in the process of change, from delivery drivers to senior partners, they facilitated a smoother transition to the new Pharmacy model. Activities such as fun team events, open discussions, and regular check-ins helped ensure ongoing feedback and fostered team morale. Kristina's approach to communication included structured input from staff, such as "Shark Tank"-style pitch sessions, which allowed for innovation-driven decisions within the team. Kristina's passion for reshaping community Pharmacy extends to their vision for a patient-centred approach that moves away from a volume-driven model. They believe that providing accessible, affordable healthcare and fostering happier Pharmacists are integral to improving patient outcomes. With the rise of automation and AI in Pharmacy practice, Kristina highlights the importance of emotional intelligence and effective communication in maintaining strong relationships within Pharmacy teams and with patients. By sharing their insights and offering support to others, Kristina hopes to inspire further industry-wide change. #CommunityPharmacy #HealthcareInnovation #PatientCare #Complete Care #EmotionalIntelligence #PharmacyAutomation #AIinPharmacy #FutureOfPharmacy #HealthcareLeadership #PharmacistRoles

Tim Ulbrich, YFP Co-Founder welcomes back David Zgarrick, PhD to share his journey into "preferment," balancing retirement, financial planning, and staying engaged through teaching and consulting. Summary In this episode, Tim Ulbrich, YFP Co-Founder, welcomes back David Zgarrick, PhD, as he shares his journey into what he calls the "preferment phase" of life. Dr. Zgarrick opens up about his transition from academia to retirement, the joy of new routines, and the power of early financial planning. He highlights the importance of staying engaged—through consulting, teaching, and meaningful activities—while keeping financial health in check. About Today's Guest David P. Zgarrick, PhD, is Professor Emeritus in the School of Pharmacy and Pharmaceutical Sciences at Northeastern University. Prior to his retirement in 2022, his positions included Associate Dean of Faculty at Northeastern's Bouvé College of Health Sciences, Acting Dean of the Northeastern's School of Pharmacy and Pharmaceutical Sciences, Chair of the Northeastern's Department of Pharmacy and Health Systems Sciences; John R. Ellis Distinguished Chair of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences; and Vice-chair of Pharmacy Practice at Midwestern University Chicago College of Pharmacy. He is a licensed pharmacist, receiving a BS in Pharmacy from the University of Wisconsin - Madison and a MS and PhD in Pharmaceutical Administration from The Ohio State University. Dr. Zgarrick remains engaged in the profession of pharmacy, consulting with universities and teaching pharmacy practice management and entrepreneurship in the health sciences. His scholarly interests include pharmacy workforce research, pharmacy management and operations, pharmacy education, and development of post-graduate programs. He has published over 150 peer-reviewed manuscripts and abstracts, was co-editor of the textbook Pharmacy Management: Essentials for All Practice Settings, and authored the book Getting Started as a Pharmacy Faculty Member. He was editor-in-chief of the Journal of Pharmacy Teaching, Executive Associate Editor of Currents in Pharmacy Teaching and Learning, and is an editorial board member of Research in Social and Administrative Pharmacy. Dr. Zgarrick is active in many professional organizations, including the American Pharmacists Association (APhA) and the American Association of Colleges of Pharmacy (AACP). He served on AACP Board of Directors for twelve years in three different roles, including as Treasurer from 2016-22. Dr. Zgarrick also served on the Board of Visitors for the University of Wisconsin School of Pharmacy, the Board of Grants for the American Foundation for Pharmaceutical Education, and is a Fellow of the American Pharmacists Association. Mentioned on the Show Episode 291: Redefining Retirement with David Zgarrick, Ph.D. Facebook David Zgarrick LinkedIn David Zgarrick Instagram @davidzgarrick  YFP YouTube Channel  YFP Book a Discovery Call YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn Tim Baker on LinkedIn YFP on Instagram YFP Facebook Group  

We continue our conversation with Dr. Jessica Burchette, Associate Professor of Pharmacy Practice at East Tennessee State University Bill Gatton College of Pharmacy, and dig deeper into the pharmacotherapy and patient care course. She is a clinical pharmacist who helped lead the recent curriculum changes at the college.

How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don't miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care! HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTColby Burns, PharmDClinical Pharmacist, CHAS HealthcarePresident, Psychedelic Pharmacist AssociationOwner/Host, Neural Pharm Online Platform and PodcastPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.0.05 CEU/0.5 HrUAN: 0107-0000-25-023-H01-PInitial release date: 1/13/2025Expiration date: 1/13/2026Additional CPE details can be found here.

Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don't miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care!HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTColby Burns, PharmDClinical Pharmacist, CHAS HealthcarePresident, Psychedelic Pharmacist AssociationOwner/Host, Neural Pharm Online Platform and PodcastPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.0.05 CEU/0.5 HrUAN: 0107-0000-25-023-H01-PInitial release date: 1/13/2025Expiration date: 1/13/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

On this episode of IPA's What, Why & How podcast, Kate Gainer welcomes pharmacy colleagues from Idaho and Alaska to share what standard of care means in their respective states and how this regulatory framework allows pharmacists to better care for their patients. To Learn More: Standard of Care Resources | Standard of Care Symposium (February 22, 2025) Jennifer Adams, PharmD, EdD, a graduate of Boise State University, Idaho State University and The George Washington University, is currently employed as Associate Dean for Academic Affairs at Idaho State University. Her previous experience includes working in hospital and community pharmacy settings, as well as at the American Pharmacists Association (APhA), helping student pharmacists develop as professionals and leaders in the profession. Dr. Adams also served for nearly 10 years as the Senior Student Affairs Advisor at the American Association of Colleges of Pharmacy (AACP), providing leadership and oversight for national student affairs activities and recruitment. Nicki Chopski earned her PharmD from Idaho State University College of Pharmacy in 1997. In 2007, as a hospital pharmacist, Nicki was appointed to the Idaho Board of Pharmacy, serving for 12 years before becoming its Executive Director in 2019. In her current role as Bureau Chief of Health Professions for the Idaho Division of Occupational and Professional Licenses, she serves as the Executive Officer for the Boards of Medicine, Nursing and Pharmacy. Brandy Seignemartin, PharmD, Executive Director of the Alaska Pharmacy Association and Clinical Assistant Professor at the UAA ISU Doctor of Pharmacy Program, has a longstanding commitment to advancing the pharmacy profession. A graduate of The Washington State University College of Pharmacy and Pharmaceutical Sciences, Dr. Seignemartin's passion for advocacy took root during her time as a student pharmacist, where she successfully led the passage of legislation in the Washington State legislature allowing interprofessional precepting between nursing, pharmacy, and medicine. In her academic role, Dr. Seignemartin is dedicated to mentoring the next generation of pharmacists, receiving the Most Influential Faculty Award in 2024. Ashley Schaber, PharmD, MBA, BCPS, is currently the Chair of the Alaska Board of Pharmacy. She graduated pharmacy school from the University of Georgia in 2006, completed a pharmacy practice residency, and has worked in health system pharmacy since 2007. She is board certified in Pharmacotherapy and holds her Master's of Business Administration with a focus on healthcare.

In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Explore the complexities of legal liabilities and risks associated with pharmacy clinical services, such as point-of-care testing (POCT) and immunization administration. This episode will offer strategies for managing potential legal challenges, including handling adverse reactions and sensitive patient results while ensuring compliance with legal and regulatory standards. Listen to this episode and equip yourself with the knowledge to navigate these challenges and provide safe, effective care to your community. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTDavid Brushwood, RPh, JDSenior LecturerU of WyomingPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify potential legal risks and liabilities associated with various pharmacy clinical services.2. Describe strategies to manage adverse events and patient outcomes in compliance with legal and regulatory requirements.0.05 CEU/0.5 HrUAN: 0107-0000-24-295-H03-PInitial release date: 11/18/2024Expiration date: 11/18/2025Additional CPE details can be found here.

Explore the complexities of legal liabilities and risks associated with pharmacy clinical services, such as point-of-care testing (POCT) and immunization administration. This episode will offer strategies for managing potential legal challenges, including handling adverse reactions and sensitive patient results while ensuring compliance with legal and regulatory standards. Listen to this episode and equip yourself with the knowledge to navigate these challenges and provide safe, effective care to your community.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTDavid Brushwood, RPh, JDSenior LecturerU of Wyoming Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify potential legal risks and liabilities associated with various pharmacy clinical services.2. Describe strategies to manage adverse events and patient outcomes in compliance with legal and regulatory requirements.0.05 CEU/0.5 HrUAN: 0107-0000-24-295-H03-PInitial release date: 11/18/2024Expiration date: 11/18/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman,  Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the relevancy of the Beers Criteria in clinical practice, examining how recent changes impact medication safety and prescribing practices for older adults. Learn strategies for effective deprescribing and discover best practices for applying these criteria to improve patient outcomes. This essential episode equips healthcare professionals with the knowledge needed to navigate complex medication regimens and advocate for safer prescribing practices. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKristin Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesREFERENCEAmerican Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adultsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss recent updates to the Beers Criteria and their impact on medication safety for older adults.2. Describe evidence-based strategies to implement the Beers Criteria and manage complex medication regimens in clinical practice.0.05 CEU/0.5 HrUAN: 0107-0000-24-282-H01-PInitial release date: 10/28/2024Expiration date: 10/28/2025Additional CPE details can be found here.Looking for more? Check out our course on deprescribing in older adults: Less is More: A Patient-Centered Approach to Deprescribing for Older Adults1 hour  |  On DemandPolypharmacy in older adults leads to significant health risks and increased costs. Learn how to effectively engage in deprescribing, using patient-centered and evidence-based approaches to reduce unnecessary medications. Enroll in this course to enhance your skills in facilitating safer medication practices, become a leader in deprescribing, and improve patient outcomes!

This episode discusses the relevancy of the Beers Criteria in clinical practice, examining how recent changes impact medication safety and prescribing practices for older adults. Learn strategies for effective deprescribing and discover best practices for applying these criteria to improve patient outcomes. This essential episode equips healthcare professionals with the knowledge needed to navigate complex medication regimens and advocate for safer prescribing practices.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKristin Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesREFERENCEAmerican Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adultsPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss recent updates to the Beers Criteria and their impact on medication safety for older adults.2. Describe evidence-based strategies to implement the Beers Criteria and manage complex medication regimens in clinical practice.0.05 CEU/0.5 HrUAN: 0107-0000-24-282-H01-PInitial release date: 10/28/2024Expiration date: 10/28/2025Additional CPE details can be found here.Looking for more? Check out our course on deprescribing in older adults:Less is More: A Patient-Centered Approach to Deprescribing for Older Adults1 hour  |  On DemandPolypharmacy in older adults leads to significant health risks and increased costs. Learn how to effectively engage in deprescribing, using patient-centered and evidence-based approaches to reduce unnecessary medications. Enroll in this course to enhance your skills in facilitating safer medication practices, become a leader in deprescribing, and improve patient outcomes!Follow CEimpact on Social Media:LinkedInInstagram

This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we dive into the transformative power of functional medicine and its potential to revolutionize pharmacy practice. That's right – we said revolutionize! Discover how addressing root causes, rather than just symptoms, is changing the way pharmacists approach patient care. Don't you want to become a leader in this evolving field and elevate your practice site?! HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJosie Phillips-Ross, PharmD, ABAAHP, FAAMMPharmacist in ChargePhillips Family Pharmacy and Functional PharmD ConsultingPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the core principles of functional medicine and their application in pharmacy practice.2. Identify key differences between conventional pharmaceutical care and functional medicine approaches.0.05 CEU/0.5 HrUAN: 0107-0000-24-281-H01-PInitial release date: 10/21/2024Expiration date: 10/21/2025Additional CPE details can be found here.Take your pharmacy practice to the next level with our comprehensive course on functional medicine:Beyond Prescriptions: A Pharmacists' Guide to Functional Medicine6hr 30min  |  On DemandLearn how functional medicine's patient-centered approach can impact the reduction of chronic diseases and how pharmacy teams can integrate functional medicine principles into daily pharmacy workflow. Course content will explain the influence of physiological processes on health and disease, and provide strategies for creating personalized treatment plans using functional medicine tools, resources, and patient case studies. Complete this course to excel in the essentials of functional medicine and lead the way in modern pharmacy care!

Join us as we dive into the transformative power of functional medicine and its potential to revolutionize pharmacy practice. That's right – we said revolutionize! Discover how addressing root causes, rather than just symptoms, is changing the way pharmacists approach patient care. Don't you want to become a leader in this evolving field and elevate your practice site?!HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJosie Phillips-Ross, PharmD, ABAAHP, FAAMMPharmacist in ChargePhillips Family Pharmacy and Functional PharmD Consulting Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the core principles of functional medicine and their application in pharmacy practice.2. Identify key differences between conventional pharmaceutical care and functional medicine approaches.0.05 CEU/0.5 HrUAN: 0107-0000-24-281-H01-PInitial release date: 10/21/2024Expiration date: 10/21/2025Additional CPE details can be found here.Take your pharmacy practice to the next level with our comprehensive course on functional medicine:Beyond Prescriptions: A Pharmacists' Guide to Functional Medicine 6hr 30min  |  On DemandLearn how functional medicine's patient-centered approach can impact the reduction of chronic diseases and how pharmacy teams can integrate functional medicine principles into daily pharmacy workflow. Course content will explain the influence of physiological processes on health and disease, and provide strategies for creating personalized treatment plans using functional medicine tools, resources, and patient case studies. Complete this course to excel in the essentials of functional medicine and lead the way in modern pharmacy care!Follow CEimpact on Social Media:LinkedInInstagram

Dr. Brooke Griffin, founder of Bold Idea Group, shares her career journey in pharmacy academia to launching her own coaching business.  This episode is brought to you by First Horizon. Summary In this inspiring episode, Tim Ulbrich introduces Dr. Brooke Griffin, a coach, mentor, and founder of Bold Idea Group. Dr. Griffin shares her career journey in academia to eventually launching her own business, and opens up about the challenges and triumphs of her path, including the bold steps she took and valuable lessons she has learned along the way.  This conversation is packed with practical wisdom for anyone seeking career fulfillment and personal growth. Whether you're just starting your career or looking to make meaningful changes, Dr. Griffin's journey and insights are sure to inspire you to take bold steps toward your own growth. About Today's Guest Brooke Griffin, PharmD, BCACP is a Professor of Pharmacy Practice and Vice Chair of Clinical Services at Midwestern University College of Pharmacy, Downers Grove. With over 20 years of experience in various ambulatory care clinics, she has worked on several multidisciplinary teams and precepted hundreds of students and residents. She is a Professional Coach in Life & Work and is passionate about offering career support through a thought-provoking and creative process. She is a coach and mentor through several pharmacy organizations and speaks nationally on various professional development topics, including the importance of coaching and mentoring, time management, and work/life integration. In 2022 she launched Bold Idea Group with a mission to inspire bold ideas from within. Her motivational podcast, Today's Bold Idea, offers a five minute inspirational boost to start your day. She is on this self-development journey alongside all of you and believes “every pharmacist deserves a coach.” Mentioned on the Show First Horizon Pharmacist Home Loan “Aliquot Investing: Small Investments in Big Real Estate Deals” Webinar on October 7th at 9pm/Eastern  Griffin B, Vest K, Pohl S, Mazan J, Winkler S. Part-time and job-share careers among pharmacy practice faculty members. Am J Pharm Educ. 2014 Apr 17;78(3):49. Destruct Yourself Podcast with Whitney Johnson Bold Idea Facebook Group Brooke Griffin LinkedIn Bold Idea Group  Today's Bold Idea Podcast  The Pharmacist's Voice®  Looking for other episodes on pharmacist businesses or side hustles? Episode 352: Pharmacy Innovators with Kelley Carlstrom, PharmD, BCOP Episode 307: Pharmacy Innovators with Dr. Izabella Wentz (The Thyroid Pharmacist) Episode 327: Pharmacy Innovators with Dr. Natalie Park (Pharmesol) Episode 289: Building Pricklee with Pharmacy Entrepreneur Kun Yang Episode 287: Monetizing Your Clinical Expertise with Dr. Timothy Gauthier YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group

Special guest Lori A. Wilken, PharmD, FCCP, BCACP, NCTTP, AE-C, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago, joins us to talkabout Asthma and COPD treatment.Listen in as we discuss answers to your big questions about treatment of asthma and COPD. You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Wilken reports relevant financial relationships [pulmonary] with AstraZeneca/Simpson Healthcare, OptumRx. (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Biologics and Inhalation Medications for AsthmaChart: Inhaled Medications for COPDIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices.  They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Dr. Lisa Lubsch is a Clinical Professor in the Department of Pharmacy Practice at the Southern Illinois University Edwardsville School of Pharmacy and Clinical Pharmacy Specialist at SSM Health Cardinal Glennon Children's Hospital in St. Louis.  She provides care to children with cystic fibrosis and other pulmonary problems.  Dr. Lubsch received the B.S. and Doctorate of Pharmacy from the St. Louis College of Pharmacy and completed a pediatric specialty residency at the Texas Tech University Health Sciences Center School of Pharmacy. She is board certified in pediatric pharmacy and fellow in the Pediatric Pharmacy Association.

Join Kristin as she chats with Rebekah Moles about fever. Rebekah is an Associate Professor in Pharmacy Practice at the University of Sydney and she is passionate about quality use of medicines in paediatric patients. She has conducted research on the management of common ailments such as fever and cough/cold in young patients.

This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.HostJen Moulton, BSPharmPresident, CEimpactGuests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD,BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organismsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN: 0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN:  0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In this episode, listen in as our expert panelists discuss tips for creating successful learning experiences for students and residents.  We'll review various teaching tools and summarize strategies for incorporating learners into your practice. We'll also discuss different approaches for providing meaningful feedback and managing challenging situations with learners.Our panel for this conversation includes: Andrea Darby Stewart, MD; Associate Director, Honor Health Family Medicine Residency Program; Clinical Professor of Family, Community & Occupational Medicine, University of Arizona College of Medicine – PhoenixMary Franks, MSN, APRN-FPA, FNP-C; Nurse Planner, NetCE; Adjunct Professor, Bradley University; Nurse Practitioner, Carle HealthMegan Smith, PharmD, BCACP; Associate Professor, College of Pharmacy, University of Arkansas for Medical Sciences (UAMS); Residency Program Director, UAMS Community-Based Residency ProgramCraig D. Williams, PharmD, FNLA, BCPS; Clinical Professor of Pharmacy Practice, Oregon Health and Science UniversityNone of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Toolbox: Preceptor's GuideFAQ: Prevention and Management of Burnout for Healthcare Professionals If you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, Our guest, Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt's Life Sciences Department. Her practice focuses on healthcare law; Food, Drug Cosmetic law; pharmacy law and regulatory issues; PBM issues; as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters). Dr. Rumore has over 15 years of law firm experience in the area of Food, Drug & Cosmetic Law and pharmaceutical intellectual property, counseling on early market opportunities for pharmaceutical clients particularly in the area of ANDA and 510K applications and all facets of Paragraph IV litigation.Dr. Rumore has also worked in Drug Regulatory Affairs in the pharmaceutical industry and hospital pharmacy, both at the Director level. She taught Pharmacy Law and Drug Regulatory Affairs at Arnold & Marie Schwartz College of Pharmacy and Touro College of Pharmacy for close to 20 years and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University.She is a frequent lecturer and has over 200 publications and presentations. Additionally, Dr. Rumore is a Fellow and former Trustee of the American Pharmacists Association, a former Board member of the American Society for Pharmacy Law and the Accreditation Council for Pharmacy Education and is a three-time recipient of the Larry Simonsmeier Legal Writing Award.This in-depth discussion on the current regulatory landscape for compounding pharmacies will look at:Current Regulatory Environment for 503A and 503B CompoundingState Laws and State Board of Pharmacy 2023/2024Important Regulatory Considerations in the 503B to 503A Compounding Model for Community Pharmacies506e Shortages and BeyondUSP 797/795 Six Months LaterGuest - Martha Rumore Senior Counsel mrumore@frierlevitt.com 646.970.3226Host - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.com  https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook@HillBlackburn Twitter ★ Support this podcast on Patreon ★

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.HostJen Moulton, BSPharmPresident, CEimpactGuest Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa ClinicReferenceGuidelinesPaperPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa Clinic ReferenceGuidelinesPaper Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay its onset. The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine.HostJen Moulton, BSPharmPresident, CEimpactGuest Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferenceThe recombinant shingles vaccine is associated with lower risk of dementiaPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe dementia's epidemiology and the significance of preventive interventions.2. Discuss the strengths, weaknesses, and outcomes of the study.0.05 CEU/0.5 HrUAN: 0107-0000-24-246-H01-PInitial release date: 08/19/2024Expiration date: 08/19/2025Additional CPE details can be found here.

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset. The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceThe recombinant shingles vaccine is associated with lower risk of dementia Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe dementia's epidemiology and the significance of preventive interventions.2. Discuss the strengths, weaknesses, and outcomes of the study.0.05 CEU/0.5 HrUAN: 0107-0000-24-246-H01-PInitial release date: 08/19/2024Expiration date: 08/19/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. HostJen Moulton, BSPharmPresident, CEimpactGuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPrevious GameChangers on PREVENT score Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In this episode, Lucas Hill, PharmD, AAHIVP, BCACP, and Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP,discuss what pharmacists need to know to provide high-quality HIV care beyond viral suppression, including treatment strategies and tips for addressing and improving patients' quality of life.Listen as they discuss:Reasons to consider regimen optimization in the setting of viral suppressionEvidence that LA ART may reduce internalized stigma​DHHS recommendations on proviral DNA genotyping​ FacultyLucas Hill, PharmD, AAHIVP, BCACP​HIV Pharmacist Specialist​UC San Diego Owen Clinic​Assistant Clinical Professor​UC San Diego Skaggs School of Pharmacy​San Diego, CaliforniaBernadette Jakeman, PharmD, PhC, BCPS, AAHIVP​|Associate Clinical Professor​Department of Pharmacy Practice and Administrative Sciences​University of New Mexico College of Pharmacy​Albuquerque, New Mexico

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss. The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.HostJen Moulton, BSPharmPresident, CEimpactGuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.0.05 CEU/0.5 HrUAN: 0107-0000-24-238-H01-PInitial release date: 07/29/2024Expiration date: 07/29/2025Additional CPE details can be found here.

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.  The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridad ReferencesTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.0.05 CEU/0.5 HrUAN: 0107-0000-24-238-H01-PInitial release date: 07/29/2024Expiration date: 07/29/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death. The GameChangerThe study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer. HostJen Moulton, BSPharmPresident, CEimpactGuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEO, SeguridadReferencesMulti-Vitamin StudyNIH Press ReleasePharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of multivitamins.2. Identify implications for healthy patients considering multivitamin use.0.05 CEU/0.5 HrUAN: 0107-0000-24-226-H01-PInitial release date: 07/22/2024Expiration date: 07/22/2025Additional CPE details can be found here.

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death. The GameChangerThe study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEO, SeguridadReferencesMulti-Vitamin StudyNIH Press Release Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of multivitamins.2. Identify implications for healthy patients considering multivitamin use.0.05 CEU/0.5 HrUAN: 0107-0000-24-226-H01-PInitial release date: 07/22/2024Expiration date: 07/22/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Welcome to "Little Minds, Big Focus: ADHD Adventures in Pediatrics," where we explore the latest insights and strategies for treating ADHD in children. Join us as we navigate the unique challenges and triumphs of pediatric ADHD, offering expert advice, personal stories, and practical tips for parents and caregivers with our guest Dr. Lea Eiland. Tune in to discover the latest treatment guidelines, clinical pearls about stimulants and non-stimulants and non-pharmacological modalities for ADHD. Guest info: Dr. Lea Eiland is a Clinical Professor and Associate Department Head of Pharmacy Practice at Auburn University, Harrison College of Pharmacy. Dr. Eiland received her Doctor of Pharmacy degree from The University of Texas at Austin and completed a pediatric specialty residency at Texas Tech University. She joined the Auburn faculty in 2002 and is a board-certified pharmacotherapy and pediatric pharmacy specialist who has practiced in the general pediatric inpatient setting, pediatric ICU, and various pediatric clinics. Dr. Eiland is an active member of ASHP, PPA, ACCP, and AACP. She is currently a member of the PPA Board of Directors. She is a past member of the ASHP Board of Directors and past President of the Alabama Society of Health-System Pharmacists. Her career focuses on pharmacy education, pediatric clinical practice, professional organizational service, research/scholarship, mentorship, and leadership.

On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.  The GameChangerRecurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.  HostJen Moulton, BSPharmPresident, CEimpactGuest Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferenced-Mannose for Prevention of Recurrent Urinary Tract Infection Among WomenA Randomized Clinical TrialPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs.2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.0.05 CEU/0.5 HrUAN: 0107-0000-24-220-H01-PInitial release date: 07/08/2024Expiration date: 07/08/2025Additional CPE details can be found here.

In episode three of our Community-based Solutions for Substance Use Challenges season, Just Science sits down with Dr. Chris Delcher, Associate Professor in the Department of Pharmacy Practice and Science and Director of the Institute for Pharmaceutical Outcomes and Policy at the University of Kentucky, to discuss how his team tracks community drug use through wastewater analysis. Much like analyzing a urine sample to determine what drugs an individual is using, analyzing wastewater from a community offers insight into drug trends across an entire region of people. The NIJ-funded weTEST program allows for the collection and analysis of wastewater from rest areas and truck stops in Kentucky to track current drug trends in a timely manner. Listen along as Dr. Delcher discusses his inspiration for using wastewater to monitor drug use, the sometimes-messy process of collecting wastewater samples, and how scientists approach ethical considerations that come with collecting data from wastewater systems. This Just Science season is supported, in part, by RTI Award No. 15PNIJ-21-GK-02192-MUMU, awarded by the National Institute of Justice, and by RTI Award No. 15PBJA-23-GK-02250-COAP, awarded by the Bureau of Justice Assistance. Both are agencies within the Office of Justice Programs, U.S. Department of Justice.

This podcast explores pharmacists' perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pharmacy. Key Concepts Generative AI with large language models (LLMs) have already changed how healthcare is delivered to patients. In the future, these changes will be more substantial and require pharmacists and other healthcare professionals to understand the benefits and downsides of this technology. Commercial LLMs, such as ChatGPT, are not HIPAA compliant and should not be used with protected health information. Companies currently offer software products that are HIPAA compliant and can integrate directly into electronic health records in a HIPAA-compliant manner. Currently, most commercial use cases of LLMs for healthcare providers focus on expediting or simplifying the documentation process (e.g. generating a first draft of a progress note or summarizing a patient encounter from an audio recording). In the future, LLMs will be used to perform a variety of clinical tasks, including drug interaction checking, renal dose adjustments, duplication of therapy, and even the appropriateness of a patient's drug regimen for a given medical condition. These clinical tasks will almost certainly be done as a “first pass” to highlight or flag specific aspects of a patient's chart and will then be reviewed by a licensed (human) healthcare provider as a final check prior to clinical decisions being made. References Large Language Models (LLMs) referenced in the episode: https://chat.openai.com, https://coral.cohere.com, https://claude.ai, https://gemini.google.com. Prompt Engineering Guide (https://www.promptingguide.ai/techniques) OpenAI - Prompt engineering (https://platform.openai.com/docs/guides/prompt-engineering/six-strategies-for-getting-better-results)